John W. Smither, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 773 shares at $34.20 ($26K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Scheduled sale ($26k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-02-12 | $98K | — | Filing → |